XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balances at Jul. 02, 2022 $ 124,878 $ 47,474 $ 77,830 $ (425)
Beginning balances (in shares) at Jul. 02, 2022   10,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock appreciation rights (in shares)   0    
Share-based compensation   $ 178    
Exercise of stock appreciation rights   0    
Net income (loss) 4,094   4,094  
Unrealized gain (loss) on hedging instruments, net of tax 270     270
Ending balances at Apr. 01, 2023 129,421 $ 47,652 81,924 (155)
Ending balances (in shares) at Apr. 01, 2023   10,762    
Beginning balances at Dec. 31, 2022 127,311 $ 47,576 79,948 (213)
Beginning balances (in shares) at Dec. 31, 2022   10,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock appreciation rights (in shares)   0    
Share-based compensation   $ 76    
Exercise of stock appreciation rights   0    
Net income (loss) 1,976   1,976  
Unrealized gain (loss) on hedging instruments, net of tax 58     58
Ending balances at Apr. 01, 2023 129,421 $ 47,652 81,924 (155)
Ending balances (in shares) at Apr. 01, 2023   10,762    
Beginning balances at Jul. 01, 2023 $ 130,617 $ 47,728 82,986 (97)
Beginning balances (in shares) at Jul. 01, 2023 10,762 10,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock appreciation rights (in shares)   0    
Share-based compensation   $ 163    
Exercise of stock appreciation rights   0    
Net income (loss) $ (802)   (802)  
Unrealized gain (loss) on hedging instruments, net of tax 97     97
Ending balances at Mar. 30, 2024 $ 130,075 $ 47,891 82,184 0
Ending balances (in shares) at Mar. 30, 2024 10,762 10,762    
Beginning balances at Dec. 30, 2023 $ 132,435 $ 47,839 84,405 191
Beginning balances (in shares) at Dec. 30, 2023   10,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock appreciation rights (in shares)   0    
Share-based compensation   $ 52    
Exercise of stock appreciation rights   0    
Net income (loss) (2,221)   (2,221)  
Unrealized gain (loss) on hedging instruments, net of tax (191)     (191)
Ending balances at Mar. 30, 2024 $ 130,075 $ 47,891 $ 82,184 $ 0
Ending balances (in shares) at Mar. 30, 2024 10,762 10,762